Related Experiment Video
Updated: May 16, 2026

Bacterial Expression and Purification of Human Matrix Metalloproteinase-3 using Affinity Chromatography
Published on: March 30, 2022
Computational insights into the selectivity mechanism of APP-IP over matrix metalloproteinases
Lingling Geng1, Jian Gao, Wei Cui
1School of Chemistry and Chemical Engineering, Graduate University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China.
Abstract:
In this work, selectivity mechanism of APP-IP inhibitor (β-amyloid precursor protein-derived inhibitory peptide) over matrix metalloproteinases (MMPs including MMP-2, MMP-7, MMP-9 and MMP-14) was investigated by molecular modeling methods. Among MMPs, MMP-2 is the most favorable one for APP-IP interacting based on our calculations. The predicted binding affinities can give a good explanation of the activity difference of inhibitor APP-IP. In Comparison with MMP-2/APP-IP complex, the side chain of Tyr214(MMP-7) makes the binding pocket so shallow that the whole side chain of Tyr3(APP-IP) can not be fully embraced, thus unfavorable for the N-terminal of APP-IP binding to MMP-7. The poor selectivity of APP-IP toward MMP-9 is mainly related with the decrease of interaction between the APP-IP C-terminal and MMP-9 due to the bulky side chains of Pro193 and Gln199, which is in agreement with experiment. The mutations at residues P193A and Q199G of MMP-9 alternate the binding pattern of the C-terminal of APP-IP by forming two new hydrogen bonds and hydrophobic interactions with MMP-9. The mutants favor the binding affinity of MMP-9 largely. For MMP-14/APP-IP, the large steric effect of Phe204(MMP-14) and the weak contributions of the polar residues Asn231(MMP-14) and Thr190(MMP-14) could explain why MMP-14 is non-selective for APP-IP interacting. Here, the molecular modeling methods were successfully employed to explore the selective inhibitor of MMPs, and our work gives valuable information for future rational design of selective peptide inhibitors toward individual MMP.
Insights
We investigated how β-amyloid precursor protein-derived inhibitory peptides (APP-IP) interact with matrix metalloproteinases (MMPs). Molecular modeling revealed MMP-2 is the most favorable target, explaining APP-IP activity differences and guiding future selective inhibitor design.
Area of Science:
- Biochemistry
- Computational Biology
- Drug Discovery
Background:
- Matrix metalloproteinases (MMPs) are implicated in various diseases.
- Developing selective inhibitors for MMPs is crucial for targeted therapy.
- APP-IP is a peptide inhibitor with potential activity against MMPs.
Purpose of the Study:
- To elucidate the selectivity mechanism of APP-IP against MMPs (MMP-2, MMP-7, MMP-9, MMP-14).
- To understand the molecular basis for differential binding affinities.
- To provide insights for the rational design of novel MMP inhibitors.
Main Methods:
- Molecular modeling techniques were employed.
- Binding affinities between APP-IP and various MMPs were calculated.
- Interaction sites and steric/polar effects were analyzed.
Main Results:
- MMP-2 showed the highest favorable interaction with APP-IP.
- Steric hindrance from Tyr214 in MMP-7 and bulky residues in MMP-9 affected APP-IP binding.
- Mutations in MMP-9 (P193A, Q199G) enhanced binding affinity.
- Steric and polar interactions influenced APP-IP's non-selectivity for MMP-14.
Conclusions:
- Molecular modeling successfully explained APP-IP selectivity towards MMPs.
- Understanding specific residue interactions is key to designing selective peptide inhibitors.
- This study offers valuable data for future development of targeted MMP therapies.
Related Concept Videos
Role of Matrix Metalloproteases in Degradation of ECM
A...
Overview of Cell-Matrix Interactions

